Suppr超能文献

涉及尾状叶的肝结直肠癌转移灶切除术:围手术期结果与生存情况

Resection of hepatic colorectal metastases involving the caudate lobe: perioperative outcome and survival.

作者信息

Abdalla Eddie K, Ribero Dario, Pawlik Timothy M, Zorzi Daria, Curley Steven A, Muratore Andrea, Andres Axel, Mentha Gilles, Capussotti Lorenzo, Vauthey Jean-Nicolas

机构信息

Department of Surgical Oncology-Unit 444, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77230-1402, USA.

出版信息

J Gastrointest Surg. 2007 Jan;11(1):66-72. doi: 10.1007/s11605-006-0045-3.

Abstract

PURPOSE

To examine clinical features and outcome of patients who underwent hepatic resection for colorectal liver metastases (LM) involving the caudate lobe.

PATIENTS AND METHODS

Consecutive patients who underwent hepatic resection for LM from May 1990 to September 2004 were analyzed from a multicenter database. Demographics, operative data, pathologic margin status, recurrence, and survival were analyzed.

RESULTS

Of 580 patients, 40 (7%) had LM involving the caudate. Six had isolated caudate LM and 34 had LM involving the caudate plus one or more other hepatic segments. Patients with caudate LM were more likely to have synchronous primary colorectal cancer (63% vs. 36%; P = 0.01), multiple LM (70% vs. 51%; P = 0.02) and required extended hepatic resection more often than patients with non-caudate LM (60% vs. 18%; P < 0.001). Only four patients with caudate LM underwent a vascular resection; three at first operation, one after recurrence of a resected caudate tumor. All had primary repair (vena cava, n = 3; portal vein, n = 1). Perioperative complications (43% vs. 28%) and 60-day operative mortality (0% vs. 1%) were similar (caudate vs. non-caudate LM, both P > 0.05). Pathological margins were positive in 15 (38%) patients with caudate LM and in 43 (8%) with non-caudate LM (P < 0.001). At a median follow-up of 40 months, 25 (64%) patients with caudate LM recurred compared with 219 (40%) patients with non-caudate LM (P = 0.01). Patients with caudate LM were more likely to have intrahepatic disease as a component of recurrence (caudate: 51% vs. non-caudate: 25%; P = 0.001). No patient recurred on the vena cava or portal vein. Patients with caudate LM had shorter 5-year disease-free and overall survival than patients with non-caudate LM (disease-free: 24% vs. 44%; P = 0.02; overall: 41% vs. 58%; P = 0.02).

CONCLUSIONS

Patients who undergo hepatic resection for caudate LM often present with multiple hepatic tumors and tumors in proximity to the major hepatic veins. Extended hepatectomy is required in the majority, although vascular resection is not frequently necessary; when performed, primary repair is usually possible. Despite resection in this population of patients with multiple and bilateral tumors, and despite close-margin and positive-margin resection in a significant proportion, recurrence on the portal vein or vena cava was not observed, and long-term survival is accomplished (41% 5-year overall survival).

摘要

目的

研究接受肝切除术治疗累及尾状叶的结直肠癌肝转移(LM)患者的临床特征及预后。

患者与方法

从一个多中心数据库中分析1990年5月至2004年9月期间接受肝切除术治疗LM的连续患者。分析人口统计学、手术数据、病理切缘状态、复发情况及生存率。

结果

580例患者中,40例(7%)有累及尾状叶的LM。6例为孤立性尾状叶LM,34例为累及尾状叶加一个或多个其他肝段的LM。与非尾状叶LM患者相比,尾状叶LM患者更易发生同步原发性结直肠癌(63%对36%;P = 0.01)、多发LM(70%对51%;P = 0.02),且更常需要扩大肝切除术(60%对18%;P < 0.001)。仅4例尾状叶LM患者接受了血管切除术;3例在首次手术时,1例在切除的尾状叶肿瘤复发后。均进行了一期修复(腔静脉,n = 3;门静脉,n = 1)。围手术期并发症(43%对28%)和60天手术死亡率(0%对1%)相似(尾状叶对非尾状叶LM,P均> 0.05)。15例(38%)尾状叶LM患者和43例(8%)非尾状叶LM患者病理切缘阳性(P < 0.001)。中位随访40个月时,25例(64%)尾状叶LM患者复发,而219例(40%)非尾状叶LM患者复发(P = 0.01)。尾状叶LM患者更易出现肝内疾病作为复发的一部分(尾状叶:51%对非尾状叶:25%;P = 0.001)。无患者在腔静脉或门静脉复发。尾状叶LM患者的5年无病生存率和总生存率均低于非尾状叶LM患者(无病生存率:24%对44%;P = 0.02;总生存率:41%对58%;P = 0.02)。

结论

接受肝切除术治疗尾状叶LM的患者常表现为多发肝肿瘤且肿瘤靠近主要肝静脉。大多数患者需要扩大肝切除术,尽管血管切除术不常需要;若进行血管切除术,通常可行一期修复。尽管该组患者存在多发及双侧肿瘤且有相当比例患者切缘较窄或切缘阳性,但未观察到门静脉或腔静脉复发,且实现了长期生存(5年总生存率41%)。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验